Validation of a candidate international harmonisation protocol‐compliant measurement procedure for reticulocyte counting using an erythrocyte gating strategy excluding the platelet component
Cytometry Part B: Clinical Cytometry · 2026
DOI: 10.1002/cyto.b.22265 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Cytometry Part B: Clinical Cytometry, 2026. Verfasst von Yutaka Nagai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Reticulocytes, Flow Cytometry, Erythrocytes, Blood Platelets. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The International Harmonisation Protocol (IHP) for Reticulocyte Percentage (%Retic) in CLSI‐H44‐A2 is a microscopic procedure performed on a new‐methylene‐blue‐stained blood film (NMB‐IHP). However, IHP‐compliant Measurement Procedures (MPs) based on flow cytometry (FCM) are recommended for practical and accurately assigned reference values. Thiazole orange (TO) for nucleic acid staining and CD235a immunostaining for erythrocyte gating are currently widespread for MP using FCM (TO/CD235a‐MP); however they have not been validated using NMB‐IHP. We recently developed MP using FCM with anti‐CD45/CD41a/CD61 antibodies, that are utilized for excluding platelets from the un‐nucleated blood cell fraction to select erythrocytes (TO/CD41a/CD61‐MP). The aim of this study is to validate TO/CD41a/CD61‐MP for measurement of reticulocytes as an IHP‐compliant MP. First, TO/CD235a‐MP was validated as an IHP‐compliant MP by comparing it with NMB‐IHP. Then TO/CD41a/CD61‐MP was compared with TO/CD235a‐MP. The practical utility of TO/CD41a/CD61‐MP was evaluated using XN‐2000™(Sysmex) and Celltac G + ™(Nihon Kohden) hematology analyzers to assess the accuracy of different nucleic acid staining methods. We first confirmed that TO/CD235a‐MP was consistent with NMB‐IHP, then evaluated TO/CD41a/CD61‐MP using TO/CD235a‐MP. Regression analysis demonstrated consistency between TO/CD41a/CD61‐MP and TO/CD235a‐MP, thereby establishing TO/CD41a/CD61‐MP as IHP‐compliant MP. In the accuracy assessment, the correlation coefficients to TO/CD41a/CD61‐MP were observed to be 0.97 for both hematology analyzers with %Retic ranging from 0.0 to 8.2. TO/CD41a/CD61‐MP serves effectively as an IHP‐compliant MP. This study provides the first empirical validation of FCM‐based MPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.
- Clinical Laboratory Science, Kansai University of Health Sciences, Osaka, Japan.
- Faculty of Sports and Health Science, Daito Bunka University, Saitama, Japan.
- Clinical Laboratory, Keio University Hospital, Tokyo, Japan.
- International University of Health and Welfare, Tokyo, Japan.
ORCID-Profile: Yutaka Nagai, Tomohiro Takeda, Hiromichi Matsushita, Takayuki Mitsuhashi, Masatoshi Wakui
Zitieren
APA
Nagai, Y., Takeda, T., Matsushita, H., Arai, T., Yatabe, Y., Yokota, H., Mitsuhashi, T., Wakui, M., Kawai, Y., & Kondo, H. (2026). Validation of a candidate international harmonisation protocol‐compliant measurement procedure for reticulocyte counting using an erythrocyte gating strategy excluding the platelet component. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.22265
Vancouver
Nagai Y, Takeda T, Matsushita H, Arai T, Yatabe Y, Yokota H, et al. Validation of a candidate international harmonisation protocol‐compliant measurement procedure for reticulocyte counting using an erythrocyte gating strategy excluding the platelet component. Cytometry Part B: Clinical Cytometry. 2026. doi:10.1002/cyto.b.22265
BibTeX
@article{Nagai2026,
author = {Nagai, Yutaka and Takeda, Tomohiro and Matsushita, Hiromichi and Arai, Tomoko and Yatabe, Yoko and Yokota, Hiromitsu and Mitsuhashi, Takayuki and Wakui, Masatoshi and Kawai, Yohko and Kondo, Hiroshi},
title = {Validation of a candidate international harmonisation protocol‐compliant measurement procedure for reticulocyte counting using an erythrocyte gating strategy excluding the platelet component},
journal = {Cytometry Part B: Clinical Cytometry},
year = {2026},
doi = {10.1002/cyto.b.22265}
}
EUVIMED